Inactive Instrument
TCR2 Therapeutics Inc. Stock
Stocks
TCRR
US87808K1060
Biotechnology & Medical Research
| 1 day | -5.73% |
| Manager | Title | Age | Since |
|---|---|---|---|
William Bertrand
PSD | President | 61 | 2023-05-31 |
Praveen Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/1/23 | Tang Capital Management LLC
| Others | Company | 4,394,800 | 11.1936% | |
| 6/1/23 | Issuer sale | Chief Operating Officer | 247,717 | 0.6309% | ||
| 6/1/23 | Issuer sale | Director | 60,342 | 0.1537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.73% | -15.43% | - | - | 58.11M | ||
| -2.49% | -6.35% | +51.07% | +64.95% | 65.42B | ||
| -0.63% | -3.81% | +6.95% | +88.55% | 58.91B | ||
| -2.37% | -2.22% | +22.96% | +83.44% | 55.24B | ||
| -2.09% | -5.73% | +12.42% | +109.00% | 45.66B | ||
| -1.57% | -6.65% | +13.99% | +20.56% | 41.29B | ||
| -0.93% | +1.67% | +20.83% | +45.03% | 36.82B | ||
| +0.68% | -6.58% | +130.32% | +640.68% | 34.48B | ||
| -0.80% | -1.73% | +75.29% | +56.47% | 32.5B | ||
| -1.91% | +17.41% | -28.74% | +477.82% | 31.69B | ||
| Average | -1.65% | -0.66% | +33.90% | +176.28% | 45B | |
| Weighted average by Cap. | -1.33% | -1.28% | +32.24% | +150.81% |
Employees
58
















